| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | Plasmodium falciparum Merozoite surface protein 1 (p195) |
| | (a.a.61-460) |
| | Swiss-Prot #: | P04934 |
| | Entry name: | MSP1_PLAFC |
| | Protein | Merozoite surface protein 1 (Merozoite surface antigens) (PMMSA) (p195) |
| | Gene names: | MSP-1 |
| | Organism: | Plasmodium falciparum (isolate Camp / Malaysia) |
| | Codon-optimized cDNA Clone |
| | Cat#: | RPL-0490 |
| | Description: | Applications:1. Codon-optimized cDNA sequence designed for recombinant |
| | protein production in both E.coli and Mammalian cell. The cDNA has been |
| | cloned into E.coli expression vector with 6x Histidine tag. 2. May be used as |
| | RNAi assistance to restore the loss-of-function. |
| | Tag: | A 6x histidine tag |
| | Formulation: | Liquid |
| | Storage: | -20° to -70° C. Avoid repeated freeze-thaw cycles. |
| | Recombinant Protein |
| | Cat#: | PL-0490 |
| | Source: | Recombinant protein derived from E.coli. Or Yeast |
| | Tag: | A 6x histidine tag |
| | Formulation: | Liquid |
| | Purity: | > 90%, as determined by SDS-PAGE under reducing conditions |
| | Activity: | N/A |
| | Applications: | Western Blot, may be used for other applications determined by |
| | Storage: | -20° to -70° C. Avoid repeated freeze-thaw cycles. |
| | Sequence: | | MKIIFFLCSF LFFIINTQCV THESYQELVK KLEALEDAVL TGYGLFHKEK MILNEEEITT KGASAQSGTS GTSGTSGTSG |
| | TSGTSGTSAQ SGTSGTSAQS GTSGTSAQSG TSGTSGTSGT SPSSRSNTLP RSNTSSGASP PADASDSDAK SYADLKHRVR |
| | NYLFTIKELK YPELFDLTNH MLTLCDNIHG FKYLIDGYEE INELLYKLNF YFDLLRAKLN DVCANDYCQI PFNLKIRANE |
| | LDVLKKLVFG YRKPLDNIKD NVGKMEDYIK KNKTTIANIN ELIEGSKKTI DQNKNADNEE GKKKLYQAQY DLSIYNKQLE |
| | EAHNLISVLE KRIDTLKKNE NIKELLDKIN EIKNPPPANS GNTPNTLLDK NKKIEEHEEK IKEIAKTIKF NIDSLFTDPL |
| | ELEYYLREKN KKVDVTPKSQ DPTKSVQIPK VPYPNGIVYP LPLTDIHNSL AADNDKNSYG DLMNPDTKEK INEKIITDNK |
| | ERKIFINNIK KQIDLEEKKI NHTKEQNKKL LEDYEKSKKD YEELLEKFYE MKFNNNFDKD VVDKIFSARY TYNVEKQRYN |
| | NKFSSSNNSV YNVQKLKKAL SYLEDYSLRK GISEKDFNHY YTLKTGLEAD IKKLTEEIKS SENKILEKNF KGLTHSANAS |
| | LEVYDIVKLQ VQKVLLIKKI EDLRKIELFL KNAQLKDSIH VPNIYKPQNK PEPYYLIVLK KEVDKLKEFI PKVKDMLKKE |
| | QAVLSSITQP LVAASETTED GGHSTHTLSQ SGETEVTEET EETEETVGHT TTVTITLPPK EVKVVENSIE HKSNDNSQAL |
| | TKTVYLKKLD EFLTKSYICH KYILVSNSSM DQKLLEVYNL TPEEENELKS CDPLDLLFNI QNNIPAMYSL YDSMNNDLQH |
| | LFFELYQKEM IYYLHKLKEE NHIKKLLEEQ KQITGTSSTS SPGNTTVNTA QSATHSNSQN QQSNASSTNT QNGVAVSSGP |
| | AVVEESHDPL TVLSISNDLK GIVSLLNLGN KTKVPNPLTI STTEMEKFYE NILKNNDTYF NDDIKQFVKS NSKVITGLTE |
| | TQKNALNDEI KKLKDTLQLS FDLYNKYKLK LDRLFNKKKE LGQDKMQIKK LTLLKEQLES KLNSLNNPHN VLQNFSVFFN |
| | KKKEAEIAET ENTLENTKIL LKHYKGLVKY YNGESSPLKT LSEVSIQTED NYANLEKFRV LSKIDGKLND NLHLGKKKLS |
| | FLSSGLHHLI TELKEVIKNK NYTGNSPSEN NKKVNEALKS YENFLPEAKV TTVVTPPQPD VTPSPLSVRV SGSSGSTKEE |
| | TQIPTSGSLL TELQQVVQLQ NYDEEDDSLV VLPIFGESED NDEYLDQVVT GEAISVTMDN ILSGFENEYD VIYLKPLAGV |
| | YRSLKKQIEK NIFTFNLNLN DILNSRLKKR KYFLDVLESD LMQFKHISSN EYIIEDSFKL LNSEQKNTLL KSYKYIKESV |
| | ENDIKFAQEG ISYYEKVLAK YKDDLESIKK VIKEEKEKFP SSPPTTPPSP AKTDEQKKES KFLPFLTNIE TLYNNLVNKI |
| | DDYLINLKAK INDCNVEKDE AHVKITKLSD LKAIDDKIDL FKNHNDFEAI KKLINDDTKK DMLGKLLSTG LVQNFPNTII |
| | For pricing and availability Click Here >>> |
| | Recombinant-Protein-cDNA-surface-antigens-p195-MSP-1-Plasmodium |
| | FOR in vitro RESEARCH USE ONLY. NOT FOR USE IN HUMANS. |
|
| ||||||||||||||||||||||||||||||||||
| |||||
| For cDNA or Recombinant Protein Search (Input Cat#, Gene name, Protein Name, Accession Number |
|
Copyright Bioclone Inc All rights Reserved